National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel - Disclosures as of 8/3/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

J. Pablo Arnoletti, MD

None

None

None

None

5/3/2011

Stephen Behrman, MD

None

None

None

None

7/16/2014

Edgar Ben-Josef, MD

None

None

None

None

6/7/2011

Al B. Benson III, MD, FACP, FASCO

None

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Enzon Pharmaceuticals;
Genentech, Inc.;
General Electric;
Genomic Health, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

9/5/2013

Ephraim S. Casper, MD

None

Novartis Pharmaceuticals Corporation

None

None

8/16/2012

Steven J. Cohen, MD

None

None

None

None

10/7/2013

Brian Czito, MD

None

None

None

None

8/17/2012

Michelle Duff, DPT

None

AstraZeneca Pharmaceuticals LP

None

None

6/24/2010

Joshua D.I. Ellenhorn, MD

None

None

None

None

9/29/2009

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

William G. Hawkins, MD

None

None

None

None

10/3/2013

Joseph Herman, MD

None

None

None

None

6/26/2013

John P. Hoffman, MD

None

None

None

None

4/11/2013

Srinadh Komanduri, MD

None

None

None

None

1/23/2014

Albert Koong, MD, PhD

None

None

None

None

10/3/2013

Boris W. Kuvshinoff, MD, MBA

None

None

None

None

1/19/2014

Mokenge P. Malafa, MD, FACS

None

None

None

None

10/3/2013

Joan S. McClure, MS

None

None

None

None

6/20/2014

Nipun B. Merchant, MD

None

None

None

None

1/23/2014

Sean J. Mulvihill, MD

National Cancer Institute

None

None

None

10/3/2013

Peter Muscarella II, MD

None

None

None

None

7/9/2014

Eric K. Nakakura, MD

None

None

None

None

6/26/2014

Jorge Obando, MD

None

None

None

None

10/7/2013

Martha B. Pitman, MD

None

None

None

None

1/2/2014

Aaron R. Sasson, MD

None

None

None

None

1/10/2014

Dorothy Shead, MS

None

None

None

None

8/19/2013

Margaret A. Tempero, MD

None

Abraxis Bioscience, Inc.;
Celgene Corporation;
Myriad Genetic Laboratories, Inc.;
Elsevier Publishing/OncologySTAT;
GenMab;
Medigene;
Pancreatic Cancer Action Network;
Rexahn Pharmaceuticals;
V Foundation;
Wayne D. Kuni and Joan E. Kuni Foundation;
sanofi-aventis U.S.

None

None

2/24/2014

Sarah P. Thayer, MD, PhD

None

Lustgarten Foundation

None

None

9/20/2012

Robert S. Warren, MD

None

None

None

None

11/23/2009

Samuel Whiting, MD, PhD

None

Genentech, Inc.

None

None

4/4/2012

Robert A. Wolff, MD

None

None

None

None

7/17/2014

Brian M. Wolpin, MD, MPH

None

None

None

None

10/8/2013